Inactive/Delisted stock
AEON Biopharma Stock (NASDAQ:AEON)
Previous Close
$0.66
52W Range
$0.40 - $1.24K
50D Avg
$9.13
200D Avg
$60.29
Market Cap
$794.15K
Avg Vol (3M)
$3.32M
Beta
0.26
Div Yield
-
AEON Company Profile
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.